Development and validation of a symptom-based activity index for adults with eosinophilic esophagitis. - Wikidata - wikimedia - TriplyDB

Development and validation of a symptom-based activity index for adults with eosinophilic esophagitis.

Development and validation of a symptom-based activity index for adults with eosinophilic esophagitis.

http://www.wikidata.org/entity/Q35586286

about

An Overview of the Diagnosis and Management of Eosinophilic Esophagitis Managing eosinophilic esophagitis: challenges and solutions Management of proton pump inhibitor responsive-esophageal eosinophilia and eosinophilic esophagitis: controversies in treatment approaches Systematic review with meta-analysis: pharmacological interventions for eosinophilic oesophagitis Molecular, genetic, and cellular bases for treating eosinophilic esophagitis.Pediatric Eosinophilic Esophagitis Symptom Scores (PEESS v2.0) identify histologic and molecular correlates of the key clinical features of disease.A Clinical Prediction Tool Identifies Cases of Eosinophilic Esophagitis Without Endoscopic Biopsy: A Prospective Study.Topical Steroid Therapy for the Treatment of Eosinophilic Esophagitis (EoE): A Systematic Review and Meta-Analysis.Recognition and Assessment of Eosinophilic Esophagitis: The Development of New Clinical Outcome Metrics.How to measure disease activity in eosinophilic esophagitis.Escalating incidence of eosinophilic esophagitis in Canton of Vaud, Switzerland, 1993-2013: a population-based study.Seasonal distribution of initial diagnosis and clinical recrudescence of eosinophilic esophagitis: a systematic review and meta-analysis.Therapeutic strategies in eosinophilic esophagitis: Induction, maintenance and refractory disease.Management of refractory eosinophilic oesophagitis.Systematic review with network meta-analysis: comparative effectiveness of topical steroids vs. PPIs for the treatment of the spectrum of eosinophilic oesophagitis.2015 David Y. Graham Lecture: The First Two Decades Of Eosinophilic Esophagitis-From Acid Reflux To Food Allergy.Eosinophilic esophagitis: current perspectives from diagnosis to management.Role of food and aeroallergen sensitization in eosinophilic esophagitis in adults.Diagnosis and treatment of eosinophilic esophagitis in clinical practice.Effects of eosinophilic oesophagitis on quality of life in an adult UK population: a case control study.Eosinophilic esophagitis phenotypes: Ready for prime time?Patient-reported outcome measures in dysphagia: a systematic review of instrument development and validation.Association Between Body Mass Index and Clinical and Endoscopic Features of Eosinophilic Esophagitis.Development and validation of the brief esophageal dysphagia questionnaire.Evaluation of Histologic Cutpoints for Treatment Response in Eosinophilic Esophagitis.How do gastroenterologists assess overall activity of eosinophilic esophagitis in adult patients?Eosinophilic oesophagitis: relationship of quality of life with clinical, endoscopic and histological activity.Eosinophilic esophagitis: What can we learn from Crohn's disease?Current Diagnostic and Treatment Strategies for Eosinophilic Esophagitis.Reply: To PMID 25086190.Systematic Review: Disease Activity Indices in Eosinophilic Esophagitis.Symptoms Have Modest Accuracy in Detecting Endoscopic and Histologic Remission in Adults With Eosinophilic Esophagitis.Improvement in Esophageal Distensibility in Response to Medical and Diet Therapy in Eosinophilic Esophagitis.Severity of endoscopically identified esophageal rings correlates with reduced esophageal distensibility in eosinophilic esophagitis.Eosinophilic Esophagitis: Relationship of Subepithelial Eosinophilic Inflammation With Epithelial Histology, Endoscopy, Blood Eosinophils, and Symptoms.Grade of eosinophilia versus symptoms in patients with dysphagia and esophageal eosinophilia.Dysphagia and health-related quality of life in patients with eosinophilic esophagitis: a long-term follow-up.The role of endoscopy in eosinophilic esophagitis: from diagnosis to therapy.A visual analogue scale and a Likert scale are simple and responsive tools for assessing dysphagia in eosinophilic oesophagitis.Current concepts in eosinophilic esophagitis.

P2860

Q26764785-FEACDBEC-C97D-49F9-8C85-5EAF9B8A7310 Q28069985-15CA64E6-6CE0-475E-9657-1E5964DB6071 Q28080583-1CD4E4C6-2780-4C27-B88B-3FFBA6E2978F Q28080597-4DB60BC7-CB93-4976-9545-6880315CB207 Q35537424-0F2F8E19-5867-4E52-8636-F08D88A08A9A Q35699974-BF3B88D8-B2F3-42BB-84DC-45D876E4067A Q36100530-CC9EBC12-6A6D-4415-B4AE-222B54CFDEB7 Q36751852-C4C30811-9599-4A54-B81B-221FC40F4D14 Q36848463-2C709C55-A266-46B7-9289-9FDC5701CA71 Q38557900-84FD1008-5E6B-4EE2-ACE2-32E950560B82 Q38573151-4C7931E7-80C8-491E-98A8-4224CAE9849E Q38590720-AD3363CE-73F8-4283-AEFD-7DEE33B478BE Q38629179-4FA68A0E-9A34-4751-8F3D-CB2404FA5E7B Q38680027-CE89D1D3-6A13-4086-B74B-A575D091857D Q38719009-0F9736B1-5AF5-4697-B3E2-362EC87CEA02 Q38805650-C2C81F84-DD3D-4A91-AF45-D59DE0A5E91E Q38911033-F87774D5-3716-4952-A5D8-ED76105A2348 Q38945262-E3E81CC7-7DDD-44BE-843F-DA833EC6B91D Q39155749-ECC3540A-D952-4A57-82EB-F189E239546C Q39169573-D9CA2194-FBA5-4313-AC45-E5655958FED7 Q39198682-E97D1C81-21E7-4104-B117-869304F42C54 Q39218833-E02E453C-44D1-44E2-9F89-1F9788A92FD5 Q39252119-41B35CF8-A857-4482-864A-76BC5BCCCF0F Q39629749-53E9F9A4-7F8A-42B0-BC9B-508BABF6315E Q40404957-7A9C71F1-6311-46B4-9C2B-E7DBB7883441 Q41319565-EDF72B0B-B877-4C2C-916D-275D0BD7819A Q41484757-F0237700-EDEF-4840-9078-4F36F6CCB046 Q42284241-07183A03-D35C-4DFA-9C31-06C9133A96A4 Q42374434-C3284245-FD53-477D-9B33-4B6419E1A37F Q42612453-D54B726E-1464-413D-B38D-8E005C3D3DC3 Q46058450-8321073F-72A6-4078-97ED-7F758ADC9F20 Q46789131-D2A8D28C-A3CF-47F4-BA42-2BAC9D501F4F Q47156583-556A6A47-2AB0-440B-91B6-513B3BD8B66E Q47171471-B22D3804-2471-4155-A85D-57CD8AE70F3D Q47559116-F206C8F3-4758-4372-A7FC-980E38370091 Q47960522-9FAB0DBD-ED5B-4AA9-8A51-DB36E05ACA8A Q48015444-168F233B-99E7-46B0-A118-20C2EBA78B59 Q48248127-E9F33B53-EED2-4B66-924C-263E9E5FEF1E Q48333190-391A2D17-A5C7-4CED-92D8-0BA08CA5B7E0 Q49186926-A1FCAC83-E54E-4FFA-B1F1-AE5AF0F0CFDD

P2860

Development and validation of a symptom-based activity index for adults with eosinophilic esophagitis.

http://www.wikidata.org/entity/Q35586286

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Development and validation of ...... with eosinophilic esophagitis.

@ast

Development and validation of ...... with eosinophilic esophagitis.

@en

type

label

Development and validation of ...... with eosinophilic esophagitis.

@ast

Development and validation of ...... with eosinophilic esophagitis.

@en

prefLabel

Development and validation of ...... with eosinophilic esophagitis.

@ast

Development and validation of ...... with eosinophilic esophagitis.

@en

P1433

Q35586286-3F2CACED-031F-4FA0-B783-5EC58405D902

P1476

Q35586286-D801C3E0-47FE-474D-AF66-EB71AC5099C1

P2093

Q35586286-010F6E18-CBF8-455A-BA36-A543E4410333

Q35586286-0AF84B22-021F-4AC4-9E4E-612C7F7EB8AF

Q35586286-0C54C063-7434-4DDE-9E3D-EF870B4B3426

Q35586286-1653F7DD-87DA-4EBC-AF3B-51C792F54321

Q35586286-42F855FE-3DF2-42BA-91BD-C9888872A070

Q35586286-44AE26E5-B0C3-4144-B05B-AA2D044F64E9

Q35586286-575292F2-4D3F-4715-9EC2-9B97C25D48C5

Q35586286-57BC2A37-2C16-4EFC-BD51-06B3DB5DF632

Q35586286-7B3D2426-68D3-4181-AE7F-CFF66DBAD1CF

Q35586286-8C1FB62C-3490-4EB0-8AC0-048EB6D48182

P2860

Q35586286-1268E389-F627-4966-98F8-0EC9C62DE31B

Q35586286-234884A1-D021-4362-8C0E-E01AF386C72F

Q35586286-273220A7-E9B7-42C1-909A-A115F326EB38

Q35586286-2D521515-1C55-45E1-93E7-EA65AABD0C79

Q35586286-3A30CF0F-F528-4947-B897-D5455F32F34B

Q35586286-4347F99D-AFC8-448A-ABD3-FE6E28A4E43E

Q35586286-4D9C77E0-8AAD-4E20-8B91-99AF1761D4B3

Q35586286-4E9AF512-2C51-4EF6-8225-3937D2438B60

Q35586286-698A1E2F-E367-43E8-BDA3-6028D43D79F2

Q35586286-77980A0D-0408-4935-8D6F-60B357B50D65

P304

Q35586286-26BF0E61-1B50-46BE-A2B6-8D9C4D458FCD

P31

Q35586286-1280040E-36C7-40BB-9F97-62C3BC89581D

P356

Q35586286-FF7040CC-55C4-4309-BFEE-05F0F932E8EA

P407

Q35586286-AC72B172-1573-4595-AC1B-8C5EE91E65FA

P433

Q35586286-1D79F3B8-380A-4760-AFE6-B5081BFB67FB

P478

Q35586286-0DC1B449-F002-40C3-BBBD-B14036F6927E

P50

Q35586286-2004EADF-992A-4416-82DF-4705CBBF8CF7

Q35586286-37825EED-45FB-4C4E-9889-86D8DB6AED66

Q35586286-5583FFFB-5D14-4105-89FF-BBCCF8E37FEE

Q35586286-91E2BDBC-EB8B-4397-8D07-1DBEB2BD6374

Q35586286-B0241173-C7AA-4159-9832-7518A85ACC8A

Q35586286-C2C8766D-80DA-408A-A38C-B9DAAC3BCD27

P577

Q35586286-6DF49227-F8EE-4C93-8718-03AF20CDCFF7

P5875

Q35586286-0A4F8018-F85E-4710-946D-AA837A5E00C0

P698

Q35586286-A4596203-4A77-4D6B-B5FB-39B9E0A4F6D8

P932

Q35586286-54544095-2245-4562-AFDA-1C9F17788597

P356

J.GASTRO.2014.08.028

P1433

Gastroenterology

P1476

Development and validation of ...... with eosinophilic esophagitis.

@en

P2093

Alain M Schoepfer

http://www.w3.org/2001/XMLSchema#string

Alex Straumann

http://www.w3.org/2001/XMLSchema#string

Christian Bussmann

http://www.w3.org/2001/XMLSchema#string

Elisabeth Maurer

http://www.w3.org/2001/XMLSchema#string

Emily Kern

http://www.w3.org/2001/XMLSchema#string

Evan S Dellon

http://www.w3.org/2001/XMLSchema#string

Felicity T Enders

http://www.w3.org/2001/XMLSchema#string

Fouad J Moawad

http://www.w3.org/2001/XMLSchema#string

Ikuo Hirano

http://www.w3.org/2001/XMLSchema#string

International Eosinophilic Esophagitis Activity Index Study Group

http://www.w3.org/2001/XMLSchema#string

P2860

Eosinophilic esophagitis

Patient-reported outcomes: assessment and current perspectives of the guidelines of the Food and Drug Administration and the reflection paper of the European Medicines Agency

Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance

Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups

Research guidelines for the Delphi survey technique.

Mechanical properties of the esophagus in eosinophilic esophagitis.

Epidemiology of eosinophilic esophagitis over three decades in Olmsted County, Minnesota.

Interpreting patient-reported outcome results: US FDA guidance and emerging methods.

Variation in prevalence, diagnostic criteria, and initial management options for eosinophilic gastrointestinal diseases in the United States.

A phenotypic analysis shows that eosinophilic esophagitis is a progressive fibrostenotic disease.

P304

1255-66.e21

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1053/J.GASTRO.2014.08.028

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

147

http://www.w3.org/2001/XMLSchema#string

P50

Claudia E. Kuehni

Radoslaw Panczak

Nirmala Gonsalves

Ekaterina Safroneeva

P577

2014-08-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

267749259

http://www.w3.org/2001/XMLSchema#string

P698

25160980

http://www.w3.org/2001/XMLSchema#string

P932

4425255

http://www.w3.org/2001/XMLSchema#string